Works matching IS 10837159 AND DT 2022 AND VI 27 AND IP 4

Results: 19

Impact of Therapy in Patients with Hematologic Malignancies on Seroconversion Rates After SARS-CoV-2 Vaccination.
Published in:
Oncologist, 2022, v. 27, n. 4, p. e357, doi. 10.1093/oncolo/oyac032
By:
- Guven, Deniz C;
- Sahin, Taha K;
- Akın, Serkan;
- Uckun, Fatih M
Publication type:
Article
Pembrolizumab and Trastuzumab in High Tumor Mutational Burden and POLE-Mutated HER2-Positive Refractory Breast Cancer.
Published in:
Oncologist, 2022, v. 27, n. 4, p. 245, doi. 10.1093/oncolo/oyac027
By:
- Zhang, Li;
- Chen, Yimeng;
- Lv, Yao;
- Jiao, Shunchang;
- Zhao, Weihong
Publication type:
Article
Joint-Predominant Rheumatic Complications of Immune Checkpoint Inhibitor Therapy in Patients with Thymic Epithelial Tumors.
Published in:
Oncologist, 2022, v. 27, n. 4, p. e353, doi. 10.1093/oncolo/oyac026
By:
- Mullenix, Cristina;
- Ballman, Madison;
- Chen, Haobin;
- Swift, Shannon;
- McAdams, Meredith J;
- Tsai, Yo-Ting;
- Donahue, Renee N;
- Poretta, Trina;
- Gupta, Sarthak;
- Loehrer, Patrick J;
- Schlom, Jeffrey;
- Gulley, James L;
- Rajan, Arun
Publication type:
Article
Plasma Epstein-Barr Virus MicroRNA BART8-3p as a Diagnostic and Prognostic Biomarker in Nasopharyngeal Carcinoma.
Published in:
Oncologist, 2022, v. 27, n. 4, p. e340, doi. 10.1093/oncolo/oyac024
By:
- Lin, Cheng;
- Lin, Keyu;
- Zhang, Bin;
- Su, Ying;
- Guo, Qiaojuan;
- Lu, Tianzhu;
- Xu, Yuanji;
- Lin, Shaojun;
- Zong, Jingfeng;
- Pan, Jianji
Publication type:
Article
Tyrosine Kinase Inhibitor Activity in Patients with NSCLC Harboring Uncommon EGFR Mutations: A Retrospective International Cohort Study (UpSwinG).
Published in:
Oncologist, 2022, v. 27, n. 4, p. 255, doi. 10.1093/oncolo/oyac022
By:
- Popat, Sanjay;
- Hsia, Te-Chun;
- Hung, Jen-Yu;
- Jung, Hyun Ae;
- Shih, Jin-Yuan;
- Park, Cheol Kyu;
- Lee, Seung Hyeun;
- Okamoto, Tatsuro;
- Ahn, Hee Kyung;
- Lee, Yong Chul;
- Sato, Yuki;
- Lee, Sung Sook;
- Mascaux, Celine;
- Daoud, Hasan;
- Märten, Angela;
- Miura, Satoru
Publication type:
Article
Efficacy of Infliximab Dose Escalation in Patients with Refractory Immunotherapy-Related Colitis: A Case Series.
Published in:
Oncologist, 2022, v. 27, n. 4, p. e350, doi. 10.1093/oncolo/oyac019
By:
- Harris, Jessica P;
- Postow, Michael A;
- Faleck, David M
Publication type:
Article
Evaluation of Tumor DNA Sequencing Results in Patients with Gastric and Gastroesophageal Junction Adenocarcinoma Stratified by TP53 Mutation Status.
Published in:
Oncologist, 2022, v. 27, n. 4, p. 307, doi. 10.1093/oncolo/oyac018
By:
- Wood, Anthony C;
- Zhang, Yonghong;
- Mo, Qianxing;
- Cen, Ling;
- Fontaine, Jacques;
- Hoffe, Sarah E;
- Frakes, Jessica;
- Dineen, Sean P;
- Pimiento, Jose M;
- Walko, Christine M;
- Mehta, Rutika
Publication type:
Article
Surrogacy Beyond Prognosis: The Importance of "Trial-Level" Surrogacy.
Published in:
Oncologist, 2022, v. 27, n. 4, p. 266, doi. 10.1093/oncolo/oyac006
By:
- Buyse, Marc;
- Saad, Everardo D;
- Burzykowski, Tomasz;
- Regan, Meredith M;
- Sweeney, Christopher S
Publication type:
Article
Impact of Iron-Deficiency Management on Quality of Life in Patients with Cancer: A Prospective Cohort Study (CAMARA Study).
Published in:
Oncologist, 2022, v. 27, n. 4, p. 328, doi. 10.1093/oncolo/oyac005
By:
- Gluszak, Cassandre;
- Vries-Brilland, Manon de;
- Seegers, Valérie;
- Baroin, Céline;
- Kieffer, Helene;
- Delva, Remy;
- Cornuault-Foubert, Delphine
Publication type:
Article
Genetic Evaluation for Hereditary Cancer Syndromes Among African Americans: A Critical Review.
Published in:
Oncologist, 2022, v. 27, n. 4, p. 285, doi. 10.1093/oncolo/oyab082
By:
- Khan, Ambreen;
- Rogers, Charles R;
- Kennedy, Carson D;
- Lopez, AnaMaria;
- Jeter, Joanne
Publication type:
Article
Methadone as First-line Opioid for the Management of Cancer Pain.
Published in:
Oncologist, 2022, v. 27, n. 4, p. 323, doi. 10.1093/oncolo/oyab081
By:
- Mercadante, Sebastiano;
- Adile, Claudio;
- Ferrera, Patrizia;
- Pallotti, Maria Caterina;
- Ricci, Marianna;
- Bonanno, Giuseppe;
- Casuccio, Alessandra
Publication type:
Article
Rh-Endostatin Plus Irinotecan/Cisplatin as Second-Line Therapy for Advanced Esophageal Squamous Cell Carcinoma: An Open-Label, Phase II Study.
Published in:
Oncologist, 2022, v. 27, n. 4, p. 253, doi. 10.1093/oncolo/oyab078
By:
- Hu, Zhihuang;
- Sun, Si;
- Zhao, Xinmin;
- Yu, Hui;
- Wu, Xianghua;
- Wang, Jialei;
- Chang, Jianhua;
- Wang, Huijie
Publication type:
Article
Combining Analysis of Tumor-infiltrating Lymphocytes (TIL) and PD-L1 Refined the Prognostication of Breast Cancer Subtypes.
Published in:
Oncologist, 2022, v. 27, n. 4, p. e313, doi. 10.1093/oncolo/oyab063
By:
- Ni, Yunbi;
- Tsang, Julia Y;
- Shao, Yan;
- Poon, Ivan K;
- Tam, Fiona;
- Shea, Ka-Ho;
- Tse, Gary M
Publication type:
Article
Three-Year Outcomes of a Phase II Study of Perioperative Capecitabine Plus Oxaliplatin Therapy for Clinical SS/SE N1-3 M0 Gastric Cancer (OGSG 1601).
Published in:
Oncologist, 2022, v. 27, n. 4, p. 251, doi. 10.1093/oncolo/oyab061
By:
- Matsuyama, Jin;
- Terazawa, Tetsuji;
- Goto, Masahiro;
- Kawabata, Ryohei;
- Endo, Shunji;
- Imano, Motohiro;
- Fujita, Shoichiro;
- Akamaru, Yusuke;
- Taniguchi, Hirokazu;
- Tatsumi, Mitsutoshi;
- Lee, Sang-Woong;
- Kawakami, Hisato;
- Kurokawa, Yukinori;
- Shimokawa, Toshio;
- Sakai, Daisuke;
- Kato, Takeshi;
- Fujitani, Kazumasa;
- Satoh, Taroh
Publication type:
Article
Essentials of Multiomics.
Published in:
Oncologist, 2022, v. 27, n. 4, p. 272, doi. 10.1093/oncolo/oyab048
By:
- Marshall, John L;
- Peshkin, Beth N;
- Yoshino, Takayuki;
- Vowinckel, Jakob;
- Danielsen, Håvard E;
- Melino, Gerry;
- Tsamardinos, Ioannis;
- Haudenschild, Christian;
- Kerr, David J;
- Sampaio, Carlos;
- Rha, Sun Young;
- FitzGerald, Kevin T;
- Holland, Eric C;
- Gallagher, David;
- Garcia-Foncillas, Jesus;
- Juhl, Hartmut
Publication type:
Article
Position Statement on the Diagnosis, Treatment, and Response Evaluation to Systemic Therapies of Advanced Neuroendocrine Tumors, With a Special Focus on Radioligand Therapy.
Published in:
Oncologist, 2022, v. 27, n. 4, p. e328, doi. 10.1093/oncolo/oyab041
By:
- Capdevila, Jaume;
- Grande, Enrique;
- García-Carbonero, Rocío;
- Simó, Marc;
- Olmo-García, Mª Isabel del;
- Jiménez-Fonseca, Paula;
- Carmona-Bayonas, Alberto;
- Pubul, Virginia
Publication type:
Article
Survival According to Primary Tumor Location, Stage, and Treatment Patterns in Locoregional Gastroenteropancreatic High-grade Neuroendocrine Carcinomas.
Published in:
Oncologist, 2022, v. 27, n. 4, p. 299, doi. 10.1093/oncolo/oyab039
By:
- Dasari, Arvind;
- Shen, Chan;
- Devabhaktuni, Anjali;
- Nighot, Ruda;
- Sorbye, Halfdan
Publication type:
Article
Depression, Anxiety, and Patterns of Mental Health Care Among Men With Prostate Cancer Receiving Androgen Deprivation Therapy.
Published in:
Oncologist, 2022, v. 27, n. 4, p. 314, doi. 10.1093/oncolo/oyab033
By:
- Tsao, Phoebe A;
- Ross, Ryan D;
- Bohnert, Amy S B;
- Mukherjee, Bhramar;
- Caram, Megan E V
Publication type:
Article
Cetuximab and Irinotecan With or Without Bevacizumab in Refractory Metastatic Colorectal Cancer: BOND-3, an ACCRU Network Randomized Clinical Trial.
Published in:
Oncologist, 2022, v. 27, n. 4, p. 292, doi. 10.1093/oncolo/oyab025
By:
- Lipsyc-Sharf, Marla;
- Ou, Fang-Shu;
- Yurgelun, Matthew B;
- Rubinson, Douglas A;
- Schrag, Deborah;
- Dakhil, Shaker R;
- Stella, Philip J;
- Weckstein, Douglas J;
- Wender, Donald B;
- Faggen, Meredith;
- Zemla, Tyler J;
- Heying, Erica N;
- Schuetz, Samantha R;
- Noble, Stephanie;
- Meyerhardt, Jeffrey A;
- Bekaii-Saab, Tanios;
- Fuchs, Charles S;
- Ng, Kimmie
Publication type:
Article